|
| |
| | | 68961 | | 09.01.2025 | | Accord Healthcare AG | | | | | | | 08.01.2030 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Doxorubicin Accord liposomal 20 mg/10 ml | Konzentrat zur Herstellung einer Infusionsdispersion | | L01DB01 | | | 02 | Doxorubicin Accord liposomal 50 mg/25 ml | Konzentrat zur Herstellung einer Infusionsdispersion | | L01DB01 | |
|
|
|
